Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate. Eur Urol 2009;56:237-44

European Urology

Volumn 57, Issue 2, 2010, Pages

  Drewa, Tomasz ^a   Chlosta, Piotr ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Regional Oncology Center   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

E1B PROTEIN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGENIC AGENT; PROTEIN BAD; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BNIP3; SUPEROXIDE DISMUTASE; TESTOSTERONE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER GROWTH; CASTRATION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL SURVIVAL; CLINICAL TRIAL; DRUG MEGADOSE; HUMAN; LETTER; METASTASIS; MITOSIS; PHASE 1 CLINICAL TRIAL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CLINICAL TRIALS, PHASE I AS TOPIC; HUMANS; MALE; NEOPLASM METASTASIS; ORCHIECTOMY; PROSTATIC NEOPLASMS; TESTOSTERONE; TREATMENT FAILURE;

EID: 72149132249     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.10.021     Document Type: Letter

References (3)

1. Morris M.J., Huang D., Kelly W.K., et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer. Eur Urol 56 (2009) 237-244
2. Horak C.H., Bronder J.L., Bouadis A., and Steeg P.S. Metastasis: the evasion of apoptosis. In: Srivastava R. (Ed). Apoptosis, Cell Signaling, and Human Diseases: Molecular Mechanisms. Vol 1 (2007), Humana Press, Totowa, NJ 63-96
3. Tang D.G., and Kehrer J.P. Carcinogenesis: balance between apoptosis and survival pathways. In: Srivastava R. (Ed). Apoptosis, Cell Signaling, and Human Diseases: Molecular Mechanisms. Vol 1 (2007), Humana Press, Totowa, NJ 97-119